Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 184Neoplasm Metastasis 149Neoplasms 140Leukemia, Myeloid, Acute 133Colorectal Neoplasms 131Breast Neoplasms 122Melanoma 94Ovarian Neoplasms 93Recurrence 88Prostatic Neoplasms 88Multiple Myeloma 84Pancreatic Neoplasms 76Squamous Cell Carcinoma of Head and Neck 74Lung Neoplasms 74Glioblastoma 74Lymphoma, Non-Hodgkin 67Myelodysplastic Syndromes 62Triple Negative Breast Neoplasms 58Glioma 56Precursor Cell Lymphoblastic Leukemia-Lymphoma 53Stomach Neoplasms 52Endometrial Neoplasms 50Brain Neoplasms 48Carcinoma, Renal Cell 47Small Cell Lung Carcinoma 46Lymphoma, Large B-Cell, Diffuse 46Carcinoma, Hepatocellular 45Lymphoma, Follicular 41Lymphoma, B-Cell 41Sarcoma 40

Interventions

temsirolimus 1Cetuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Patients With Advanced or Metastatic Solid Tumors × 90 days × Clear all
NCT02215720 2026-03-20

TORERO

Gustave Roussy, Cancer Campus, Grand Paris

Phase 1 Completed
45 enrolled
Other solid neoplasm

Patients With Advanced or Metastatic Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡